Issues that will need to be further clarified include the question of whether these insulin analogs have teratogenic effects on the developing fetus, alter the balance between the binding affinity to IGF-I receptor and insulin receptor, are associated with increased risk of retinopathy, or show increased antibodies levels. Here, INS is linked to retinal disorder.